A 65-Year-Old Male with Primary Central Nervous System Diffuse Large B-Cell Lymphoma on Nivolumab with Oral Mucositis and Targetoid Plaques
Conclusion: As PD-1 inhibitors become more widely used in the treatment of advanced malignancies, the early recognition and treatment of rare dermatologic toxicities remain of great importance.Dermatopathology 2017;4:13-17
Source: Dermatopathology - Category: Pathology Source Type: research
More News: Cancer & Oncology | Dermatitis | Dermatology | Immunotherapy | Incontinence | Lymphoma | Pathology | Primary CNS Lymphoma | Skin | Toxicology